Javelin plunges on recall; Synta gains
Shares of Javelin Pharmaceuticals plunges in early action after the company announces its European commercial partner was recalling all batches of its pain medication Dyloject from the U.K. market due to quality control problems.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here